Zimmer Biomet Holdings, Inc.
ZIM.DE
Deutsche Börse94.94
EUR
-0.38
- -
Zimmer Biomet Holdings, Inc.
ZIM.DE
(Deutsche Börse)
Recent
price
94.94
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Zimmer Biomet Holdings, Inc. is a global leader in musculoskeletal healthcare, designing, manufacturing and marketing orthopedic reconstructive products including knee, hip, shoulder, elbow, foot and ankle implants; S.E.T. products encompassing sports medicine, biologics, extremities and trauma solutions; craniomaxillofacial and thoracic products for face, skull and chest bone fixation and stabilization; dental implants, prosthetics and regenerative solutions; surgical instruments, bone cement and office-based technologies; and advanced integrated digital and robotic systems such as the ROSA Knee, Hip and Shoulder platforms leveraging data analytics and artificial intelligence. Founded in 1927 and headquartered in Warsaw, Indiana, the company operates in more than 40 countries including the US, Europe, Asia-Pacific and Latin America, with sales in over 100 countries, serving orthopedic surgeons, neurosurgeons, hospitals, distributors and healthcare organizations treating bone, joint and soft tissue disorders. In 2024, Zimmer Biomet announced the acquisition of OrthoGrid Systems, an AI surgical guidance company to enhance hip replacement procedures, and formalized a strategic partnership with CBRE Group, Inc. to develop and outfit orthopedic ambulatory surgery centers across the US, alongside unveiling long-term growth strategies at its Investor Day emphasizing topline expansion, profitability and free cash flow.